Table 1.
Variables | Recurrence (n = 40) | No recurrence (n = 411) | P-value |
---|---|---|---|
Age, years | 71 (60–74) | 65 (55–73) | 0.116 |
Male | 20 (50.0) | 231 (56.2) | 0.451 |
History of hypertension | 29 (72.5) | 256 (62.3) | 0.201 |
History of diabetes mellitus | 13 (32.5) | 123 (29.9) | 0.735 |
History of dyslipidemia | 21 (52.5) | 252 (61.3) | 0.276 |
History of AF | 7 (17.5) | 37 (8.9) | 0.084 |
History of ischemic stroke | 10 (25.0) | 68 (16.5) | 0.177 |
History of TIA | 6 (15.0) | 22 (5.4) | 0.038 |
History of ischemic heart disease | 4 (10.0) | 39 (9.5) | 0.916 |
Smoker | 8 (20.0) | 142 (34.5) | 0.062 |
Unilateral weakness | 25 (62.5) | 226 (55.0) | 0.213 |
Slurring speech | 15 (37.5) | 107 (26.0) | 0.361 |
Symptom duration | 0.355 | ||
≤10 min | 3 (7.5) | 63 (15.3) | |
11–60 min | 4 (10) | 50 (12.2) | |
>60 min | 33 (82.5) | 298 (72.5) | |
Systolic blood pressure, mmHg | 166 (146–182) | 160 (143–180) | 0.453 |
Diastolic blood pressure, mmHg | 80 (71–97) | 83 (74–94) | 0.949 |
NIHSS at admission | 1 (0.25–2) | 1 (0–2) | 0.893 |
Premorbid mRS | 0 (0–0) | 0 (0–0) | 0.125 |
Large artery stenosis | 25 (62.5) | 147 (35.8) | 0.001 |
New infarct | 11 (27.5) | 102 (24.8) | 0.709 |
Antiplatelet(s) | 29 (72.5%) | 320 (77.9%) | 0.916 |
Anticoagulant | 0 (0.0%) | 9 (2.2%) | 1.000 |
Antihypertensives | 19 (47.5%) | 209 (50.9%) | 0.851 |
Antidiabetics | 6 (15.0%) | 92 (22.4%) | 0.409 |
Statins | 16 (40.0%) | 182 (44.3%) | 0.984 |
AF indicates atrial fibrillation; TIA indicates transient ischemic attack; NIHSS indicates National Institute of Health Stroke Scale; mRS indicates modified Rankin Scale.